Categories: Manufacturers (D)

Sterling biotech Ltd, C – 25, Laxmi Towers, ‘A’ – 601, 6th Floor, Bandra Kurla Complex, Bandra (East) Mumbai – 400051

Company Name : Sterling biotech Ltd

Address : C – 25, Laxmi Towers, ‘A’ – 601, 6th Floor, Bandra Kurla Complex, Bandra (East) Mumbai – 400051

Tel No : 91-22-26541241/42/43

Email : apisales@sterbio.com

Website : http://www.sterlingbiotech.in/

Company Profile

Working with and developing any opportunity into reality is a mindset at Sterling Group. Sterling with its new thinking, new capabilities and sense of urgency aspires to “Earn trust, every moment” of its partners, collaborators, stake holders and customers. At Sterling Biotech Ltd. our goal is to commercialize Active Pharmaceutical Ingredient and make it available at competitive prices to our global customers.

 

Our capabilities include state of art research centre, advance pilot plant for scale up studies, modern facility of bioreactors and range of down streaming process equipments. All these are coupled with dedicated and qualified work force, well equipped quality control laboratory and quality assurance systems

 

We strive to become leaders in API pharmaceutical area by developing state of the art facility for research and development, contract manufacturing of active pharmaceutical ingredients. We build quality in every aspect of manufacturing with particular laid down emphasis based on current Good Manufacturing Practices.

 

Sterling Biotech Ltd. is committed to scaling new heights and creating new dimensions in Fermentation based API and Synthetic API . This way we shall support aspiration to “Live better and Live longer”.

 

Sterling Biotech’s manufacturing facility at Masar, Gujarat, is at par with international standards. It complies with cGMP norms complying to the standards of WHO and is in the process of getting CEP for the active pharmaceutical ingredient Epirubicin , Lovastatin

 

This adequately reflects Sterlings commitment towards quality. Efforts to attain such standards have also opened the key to gain foothold in the regulated and semi regulated markets throughout US and Europe

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

4 days ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

5 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

5 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

6 days ago